The possibility of avoiding the greatest number of deaths in Mexico from COVID-19 could be in a medicine that the National Polytechnic Institute (IPN) is currently in trial with.
Transferon, a medicine used in various autoimmune, infectious, chronic-degenerative and respiratory disorders, is being tested to be used as an aid in the treatment of patients with COVID-19.
"We are waiting for the corresponding authorizations from the authorities, both from the ethics committees and later by the health authority, to be able to start a Phase 2-3 study, which allows us to . . .
